secwatch.observer — SEC 8-K summary
======================================

Issuer:     Day One Biopharmaceuticals, Inc. (—)
CIK:        0001845337
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001193125-26-095174
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Servier to acquire Day One Biopharmaceuticals for $21.50/share in all-cash deal valued at ~$2.5B
--------------------------------------------------------------------------------

- Acquisition at $21.50/share cash, total equity value ~$2.5B; premium of ~68% over March 5 close.
- Day One board recommends tender; transaction expected to close in Q2 2026.
- Conditions: majority of shares tendered, HSR clearance; no financing condition.
- Termination fee of $87.7M payable by Day One if it accepts a superior proposal.
- Servier to fund the acquisition from existing cash and investments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845337/000119312526095174/0001193125-26-095174-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845337/000119312526095174/d108979d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-095174

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer